LOXL2 and carcinoma: In particular, breast tumor-derived lysyl oxidase-like 2 (LOXL2) was implicated in the activation of resident fibroblasts in C57Bl/6 breast carcinoma mouse model through the upregulation of α-SMA expression and the β3 integrin/FAK/AKT signaling [179].